foxo4-dri vs gdf-11

foxo4-dri vs gdf-11 The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound Molecular modelling of the FOXO4-TP53

Name: foxo4-dri vs gdf-11 The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound Molecular modelling of the FOXO4-TP53
Brand: vanierexcavation.com
SKU: 3344849737
Price: 23.30 USD
Availability: InStock
Rating: 4.7263 (8 reviews)

Molecular modelling of the FOXO4 TP53 interaction to design senolytic peptides for the elimination of senescent cancer cells eBioMedicine Peptide Inhibitors Targeting FOXO4 p53 Interactions and Inducing Senescent Cancer Cell specific Apoptosis Journal of Medicinal Chemistry FOXO4 DRI alleviates age related testosterone secretion insufficiency by targeting senescent Leydig cells in aged mice PMC Frontiers FOXO4 DRI regulates endothelial cell senescence via the P53 signaling pathway GDF11 and aging biology controversies resolved and pending PMC

SKU: 3344849737 · From vanierexcavation.com

4.7

USD23.30 USD49.30

Pay in 4 interest-free payments of $5.83 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Sep 16 - Sep 21

Description

A.et al (2021)

Blots were blocked with phosphate-buffered saline with 0.1% Tween 20 and then bound with antibodies for Biotin, after which an enhanced chemiluminescence (ECL) reaction was performed for blot development